After that between Pfizer and Allergan, is likely to skip even the marriage between Halliburton e Baker Hughes. This could be the decision of the US Justice Department, which according to Bloomberg this week could block the purchase of the rival company by the oil services giant due to competition problems.
Last December, when the Justice Department stalled before ruling on the case, Baker Hughes and Halliburton had agreed to extend the period necessary to close the operation to "no later than April 30th."
The two companies had announced a merger last November: at the time Halliburton had put up $34,6 billion, or $78,62 per share. Today, each Baker Hughes title is worth about $39.
